Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Cyclacel
Cyclacel Pharmaceuticals Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference
September 04, 2024
From
Cyclacel
Via
GlobeNewswire
Tickers
CYCC
CYCCP
Cyclacel Pharmaceuticals Confirms It Has Filed an Appeal to Nasdaq Staff Delisting Letter
September 03, 2024
From
Cyclacel
Via
GlobeNewswire
Tickers
CYCC
CYCCP
Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update
August 14, 2024
From
Cyclacel
Via
GlobeNewswire
Tickers
CYCC
CYCCP
Cyclacel Pharmaceuticals to Release Second Quarter 2024 Financial Results
August 07, 2024
From
Cyclacel
Via
GlobeNewswire
Tickers
CYCC
CYCCP
Cyclacel Announces Notice of Intention to Grant New European Patent Covering Plogosertib Pharmaceutical Compositions
June 26, 2024
From
Cyclacel
Via
GlobeNewswire
Tickers
CYCC
CYCCP
Cyclacel’s Fadraciclib Demonstrates Efficacy in Patient-Derived Colorectal Cancer Models at the 2024 ASCO Annual Meeting
June 04, 2024
From
Cyclacel
Via
GlobeNewswire
Tickers
CYCC
CYCCP
Cyclacel Pharmaceuticals Reports New Clinical Data at 2024 ASCO Annual Meeting Highlighting Oral Fadraciclib’s Potential as a Precision Medicine for Cancer
June 03, 2024
From
Cyclacel
Via
GlobeNewswire
Tickers
CYCC
CYCCP
Cyclacel Pharmaceuticals Reports First Quarter Financial Results and Provides Business Update
May 14, 2024
From
Cyclacel
Via
GlobeNewswire
Tickers
CYCC
CYCCP
Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial Results
May 08, 2024
From
Cyclacel
Via
GlobeNewswire
Tickers
CYCC
CYCCP
Cyclacel Pharmaceuticals Announces Closing of $8.0 Million Private Placement Priced At-The-Market Under NASDAQ Rules
May 02, 2024
From
Cyclacel
Via
GlobeNewswire
Tickers
CYCC
CYCCP
Cyclacel Pharmaceuticals Announces $8.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
April 30, 2024
From
Cyclacel
Via
GlobeNewswire
Tickers
CYCC
CYCCP
Cyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib’s Potential as a Precision Medicine for Cancer
April 01, 2024
From
Cyclacel
Via
GlobeNewswire
Tickers
CYCC
CYCCP
Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
March 19, 2024
From
Cyclacel
Via
GlobeNewswire
Tickers
CYCC
CYCCP
Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2023 Financial Results
March 13, 2024
From
Cyclacel
Via
GlobeNewswire
Tickers
CYCC
CYCCP
Cyclacel Pharmaceuticals Announces Preclinical Proof-of-Concept Data for Fadraciclib to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024
March 07, 2024
From
Cyclacel
Via
GlobeNewswire
Tickers
CYCC
CYCCP
Cyclacel Pharmaceuticals Announces Receipt of $2.9 Million R&D Tax Credit
March 06, 2024
From
Cyclacel
Via
GlobeNewswire
Tickers
CYCC
CYCCP
Cyclacel Pharmaceuticals to Participate in 2024 BIO CEO & Investor Conference
February 20, 2024
From
Cyclacel
Via
GlobeNewswire
Tickers
CYCC
CYCCP
Cyclacel Pharmaceuticals Announces the Appointment of Brian Schwartz, M.D. as Chief Medical Officer
January 30, 2024
From
Cyclacel
Via
GlobeNewswire
Tickers
CYCC
CYCCP
Cyclacel Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement
January 08, 2024
From
Cyclacel
Via
GlobeNewswire
Tickers
CYCC
CYCCP
Cyclacel Pharmaceuticals to Present at Biotech Showcase 2024
January 02, 2024
From
Cyclacel
Via
GlobeNewswire
Tickers
CYCC
CYCCP
Cyclacel Pharmaceuticals Announces Registered Direct and Private Placement Offering Priced At-The-Market Under Nasdaq Rules
December 22, 2023
From
Cyclacel
Via
GlobeNewswire
Tickers
CYCC
CYCCP
Cyclacel Pharmaceuticals Reports Fadraciclib Phase 1 Data Suggesting Efficacy Against Tumors With CDKN2A, CDKN2B and MTAP Deletions
December 18, 2023
From
Cyclacel
Via
GlobeNewswire
Tickers
CYCC
CYCCP
Cyclacel Pharmaceuticals Announces Reverse Stock Split
December 12, 2023
From
Cyclacel
Via
GlobeNewswire
Tickers
CYCC
CYCCP
Cyclacel Regains Compliance With Nasdaq Listing Rule Following Filing of Its Form 10-Q With the SEC
November 30, 2023
From
Cyclacel
Via
GlobeNewswire
Tickers
CYCC
CYCCP
Cyclacel Receives Notification of Deficiency From Nasdaq Regarding Timely Filing of Quarterly Report on Form 10-Q
November 28, 2023
From
Cyclacel
Via
GlobeNewswire
Tickers
CYCC
CYCCP
Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update
November 13, 2023
From
Cyclacel
Via
GlobeNewswire
Tickers
CYCC
CYCCP
Cyclacel Pharmaceuticals to Release Third Quarter 2023 Financial Results
November 07, 2023
From
Cyclacel
Via
GlobeNewswire
Tickers
CYCC
CYCCP
Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update
August 09, 2023
From
Cyclacel
Via
GlobeNewswire
Tickers
CYCC
CYCCP
Cyclacel Pharmaceuticals to Release Second Quarter 2023 Financial Results
August 03, 2023
From
Cyclacel
Via
GlobeNewswire
Tickers
CYCC
CYCCP
Cyclacel Pharmaceuticals Reports First Quarter Financial Results and Provides Business Update
May 11, 2023
From
Cyclacel
Via
GlobeNewswire
Tickers
CYCC
CYCCP
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit